Tumor necrosis factor-α antagonist use and cancer in patients with rheumatoid arthritis

被引：0
|
作者：
Setoguchi, Soko
Solomon, Daniel H.
Weinblatt, Michael E.
Katz, Jeffrey N.
Avorn, Jerry
Glynn, Robert J.
Francis Cook, E.
Carney, Greg
Schneeweiss, Sebastian
机构：
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA USA
[2] Brigham & Womens Hosp, Div Rheumatol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA
[4] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2006年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
039
引用
收藏
页码：S19 / S19
页数：1
相关论文
共 50 条
  • [21] Effects of tumor necrosis factor-α inhibitors on lung lesions with rheumatoid arthritis
    Inoue, KI
    Takano, H
    Yanagisawa, R
    Yoshikawa, T
    [J]. CHEST, 2003, 124 (01) : 413 - 414
  • [22] Efficacy of costimulation blockade with abatacept in rheumatoid arthritis patients refractory to tumor necrosis factor-α inhibition
    Moreland L.
    [J]. Current Rheumatology Reports, 2006, 8 (5) : 367 - 367
  • [23] Anti-tumor necrosis factor-α treatment improves endothelial function in patients with rheumatoid arthritis
    Hürlimann, D
    Forster, A
    Noll, G
    Enseleit, F
    Chenevard, R
    Distler, O
    Béchir, M
    Spieker, LE
    Neidhart, M
    Michel, BA
    Gay, RE
    Lüscher, TF
    Gay, S
    Ruschitzka, F
    [J]. CIRCULATION, 2002, 106 (17) : 2184 - 2187
  • [24] Anti-tumor necrosis factor-α blockade improves insulin resistance in patients with rheumatoid arthritis
    Gonzalez-Gay, MA
    De Matias, JM
    Gonzalez-Juanatey, C
    Garcia-Porrua, C
    Sanchez-Andrade, A
    Martin, J
    Llorca, J
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (01) : 83 - 86
  • [25] Extraarticular Manifestations of Rheumatoid Arthritis in Patients under Anti-tumor Necrosis Factor-α Treatment
    Bachmeyer, Claude
    Rein, Christopher
    Georgin-Lavialle, Sophie
    [J]. JOURNAL OF RHEUMATOLOGY, 2015, 42 (06) : 1059 - 1059
  • [26] The evolving use of tumor necrosis factor inhibitors in rheumatoid arthritis
    Kavanaugh, A
    Cohen, S
    Cush, JJ
    [J]. JOURNAL OF RHEUMATOLOGY, 2004, 31 (10) : 1881 - 1884
  • [27] Tumor necrosis factor antagonist responsiveness in a United States rheumatoid arthritis cohort
    Greenberg, Jeffrey D.
    Kishimoto, Mitsumasa
    Strand, Vibeke
    Cohen, Stanley B.
    Olenginski, Thomas P.
    Harrington, Thomas
    Kafka, Shelly P.
    Reed, George
    Kremer, Joel M.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2008, 121 (06): : 532 - 538
  • [28] Rheumatoid arthritis and tumor necrosis factor α
    Abe, T
    Takeuchi, T
    [J]. AUTOIMMUNITY, 2001, 34 (04) : 291 - 303
  • [29] Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors
    Chakravarty, EF
    Michaud, K
    Wolfe, F
    [J]. JOURNAL OF RHEUMATOLOGY, 2005, 32 (11) : 2130 - 2135
  • [30] Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study
    Ko-Ming Lin
    Tien-Tsai Cheng
    Jing-Chi Lin
    Chung-Jen Chen
    [J]. Clinical Rheumatology, 2015, 34 : 1039 - 1046
12345